TY - JOUR
T1 - Asbestos-related pleuropulmonary diseases
T2 - Benign and malignant
AU - Lazarus, Angeline
AU - Massoumi, Ali
AU - Hostler, Jordanna
AU - Hostler, David C.
PY - 2012/5
Y1 - 2012/5
N2 - Asbestos is known for its desirable properties of thermal and heat resistance along with excellent strength and durability. It was widely used in many industries since the late 19th century, until its adverse effects on health were recognized. The occurrence of pleuropulmonary changes from exposure to asbestos often has a latency period of 20 to 30 years. The use of asbestos has been banned, regulated, and minimized in many countries, but in several developing countries, the use of asbestos in industries is still a common practice. In this article, the benign and malignant clinical manifestations of asbestos exposure are discussed.
AB - Asbestos is known for its desirable properties of thermal and heat resistance along with excellent strength and durability. It was widely used in many industries since the late 19th century, until its adverse effects on health were recognized. The occurrence of pleuropulmonary changes from exposure to asbestos often has a latency period of 20 to 30 years. The use of asbestos has been banned, regulated, and minimized in many countries, but in several developing countries, the use of asbestos in industries is still a common practice. In this article, the benign and malignant clinical manifestations of asbestos exposure are discussed.
KW - Asbestos
KW - Asbestosis
KW - Lung cancer
KW - Pleural effusion
KW - Pleural thickening
KW - Pleuropulmonary disease
UR - http://www.scopus.com/inward/record.url?scp=84867848745&partnerID=8YFLogxK
U2 - 10.3810/pgm.2012.05.2555
DO - 10.3810/pgm.2012.05.2555
M3 - Article
C2 - 22691906
AN - SCOPUS:84867848745
SN - 0032-5481
VL - 124
SP - 116
EP - 130
JO - Postgraduate Medicine
JF - Postgraduate Medicine
IS - 3
ER -